Moran James P
SEC insider (Form 3/4/5 filer). CIK 0001907094. Director at IGC Pharma, Inc. (IGC). 7 reported Form 4/5 transactions since Sep 2024; latest on Apr 1, 2026. Located in POTOMAC, MD.
Companies Moran James P has filed insider reports for
- IGC Pharma, Inc. (IGC): Director
Moran James P
CIK: 0001907094
Transaction Breakdown
Open Market Buys (P)1 (14.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)5 (71.4%)
Derivative conversions
Awards (A)1 (14.3%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IGC
IGC Pharma, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Apr 1, 2026IGC
IGC Pharma, Inc.
ExerciseDirect80K shares- - Apr 1, 2026IGC
IGC Pharma, Inc.
ExerciseDirect50K shares- - Oct 17, 2025IGC
IGC Pharma, Inc.
AwardDirectOptions
500K shares- - Mar 31, 2025IGC
IGC Pharma, Inc.
ExerciseDirect50K shares- - Mar 31, 2025IGC
IGC Pharma, Inc.
ExerciseDirect33.3K shares- - Mar 31, 2025IGC
IGC Pharma, Inc.
ExerciseDirect80K shares- - Sep 25, 2024IGC
IGC Pharma, Inc.
PurchaseIndirect588.2K shares at avg. $0.34$200K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 1, 2026 | IGC IGC Pharma, Inc. | Exercise | 80,000 | - | $0 | Direct |
| Apr 1, 2026 | IGC IGC Pharma, Inc. | Exercise | 50,000 | - | $0 | Direct |
| Oct 17, 2025 | IGC IGC Pharma, Inc. | Award Options | 500,000 | - | - | Direct |
| Mar 31, 2025 | IGC IGC Pharma, Inc. | Exercise | 50,000 | - | - | Direct |
| Mar 31, 2025 | IGC IGC Pharma, Inc. | Exercise | 33,333 | - | - | Direct |
| Mar 31, 2025 | IGC IGC Pharma, Inc. | Exercise | 80,000 | - | - | Direct |
| Sep 25, 2024 | IGC IGC Pharma, Inc. | Purchase | 588,235 | $0.34 | $200,000 | Indirect |
1-7 of 7 transactions